BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33120763)

  • 1. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis.
    Han J; Fan YC; Wang K
    Medicine (Baltimore); 2020 Oct; 99(43):e22703. PubMed ID: 33120763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
    Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis.
    Spiliotis AE; Gäbelein G; Holländer S; Scherber PR; Glanemann M; Patel B
    Radiol Oncol; 2021 Jun; 55(3):247-258. PubMed ID: 34167181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (Eternal) Debate on Microwave Ablation
    Ricci AD; Rizzo A; Bonucci C; Tavolari S; Palloni A; Frega G; Mollica V; Tober N; Mazzotta E; Felicani C; Serra C; Brandi G
    In Vivo; 2020; 34(6):3421-3429. PubMed ID: 33144450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
    Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
    Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Yu Q; Liu C; Navuluri R; Ahmed O
    Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
    Tang Y; Zhong H; Wang Y; Wu J; Zheng J
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
    Cui R; Yu J; Kuang M; Duan F; Liang P
    J Cancer Res Ther; 2020; 16(2):379-386. PubMed ID: 32474527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q
    Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis.
    Han Y; Zhao W; Wu M; Qian Y
    Medicine (Baltimore); 2022 Dec; 101(51):e32304. PubMed ID: 36595779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
    Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.